Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3215]

Narrow subset of cells is responsible for metastasis in multiple myeloma

Narrow subset of cells is responsible for metastasis in multiple myeloma

ASH 2014: Phase II trial shows maintenance with ixazomib in newly diagnosed multiple myeloma may be feasible

ASH 2014: Phase II trial shows maintenance with ixazomib in newly diagnosed multiple myeloma may be feasible

ASH 2014: Low-molecular-weight heparin more effective than warfarin in preventing clot recurrence in cancer patients

ASH 2014: Low-molecular-weight heparin more effective than warfarin in preventing clot recurrence in cancer...

ASH 2014: Anticoagulation after incidental pulmonary embolism may reduce risk of clot recurrence in cancer patients

ASH 2014: Anticoagulation after incidental pulmonary embolism may reduce risk of clot recurrence in cancer patients

ASH 2014: Children with rare leukaemia have better-than-expected outcomes after tailored treatment

ASH 2014: Children with rare leukaemia have better-than-expected outcomes after tailored treatment

ASH 2014: First randomised evidence for benefit from adding a tyrosine kinase inhibitor in acute myeloid leukaemia

ASH 2014: First randomised evidence for benefit from adding a tyrosine kinase inhibitor in acute myeloid leukaemia

ASH 2014: Targeted therapy effective in elderly patients with Philadelphia-positive acute lymphocytic leukaemia

ASH 2014: Targeted therapy effective in elderly patients with Philadelphia-positive acute lymphocytic leukaemia

ASH 2014: Chemo-free treatment approach demonstrates positive responses in leukaemia patients

ASH 2014: Chemo-free treatment approach demonstrates positive responses in leukaemia patients

ASH 2014: Compound improves survival in aggressive acute myeloid leukaemia with manageable added toxicity in phase III trial

ASH 2014: Compound improves survival in aggressive acute myeloid leukaemia with manageable added toxicity in phase...

ASH 2014: Sotarcept reduces transfusion burden in patients with myelodysplastic syndromes

ASH 2014: Sotarcept reduces transfusion burden in patients with myelodysplastic syndromes

More from ecancer